China Bioprocess Instruments Market SizeembedDownload
China bioprocess instruments market size was estimated at USD 1.18 billion in 2016 and is expected to grow on account of the evolution of new technologies.
Your Catalyst To a Lucrative Business China Bioprocess Instruments Market Size, Share, Growth, Analysis and Forecast to 2024 - Hexa Research “China bioprocess instruments market is expected to reach USD 3.06 billion by 2024 owing to the improving economy, rising aging population and increasing prevalence of chronic diseases.” The China Bioprocess Instruments Market is expected to reach USD 3.06 billion by 2024 owing to the improving economy, rising aging population and increasing prevalence of chronic diseases. Moreover, increasing demand for single-use instruments in disposable applications is anticipated to augment the growth over the projected period. China was the second largest pharmaceutical market in the world, expected to grow USD 173 billion by 2024, growing at a CAGR of 9.1% owing to the requirement of medication & drugs to cure deadly diseases. Huge investment in biotechnology will primarily drive the growth of the market, as pharma companies deal in innovations for developing medicines and drugs in line with the increasing prevalence of diseases. Browse Details of Report @ https://www.hexaresearch.com/research-report/china-bioprocessinstruments-market Follow Us: Your Catalyst To a Lucrative Business With the patents of numerous biopharmaceutical products expiring by 2016, the market is anticipated to provide a lucrative opportunity for contract manufacturers operating in the region. Approval of the trail plan for new drug marketing authorization holder (MAH) in 2016 to produce, conduct clinical trials, and market the products is expected to provide an impetus to the growth of the industry over the next few years. Increasing demand for bioprocess instruments in the pharmaceutical, research & development, industrial and medical laboratories coupled with the increasing number of these facilities is expected to result in the growth of the market. Change in lifestyle & food consuming habits, and growing levels of air & water pollution have led to increasing occurrence of disease including obesity which has resulted in a rising number of patients diagnosed with cancer, heart disease, diabetes and other chronic conditions. Thus, the healthcare sector is anticipated to create demand for treatment and laboratory services, which will result in the growth of bioprocess instruments market over the forecast period. Stringent regulatory policies and the high cost of instruments are likely to restrain the bioprocess instruments market in China. The government has been focusing on reducing the fragmentation in the industry by consolidating manufacturers that lack standards in production with larger companies. This move will help in preventing the quality risks and sub-par manufacturers entering the market. Shortage of skilled labor is another challenge in the growth of bioprocessing industry. Koninklijke Philips N.V., Thermo Fisher Scientific Inc. and Becton, Dickinson and Company were the top three companies in the market in China in 2016. Companies are extensively investing in R&D for innov ation and new product development. In addition, companies are adopting the strategy of merger and acquisition to expand their product portfolio. Hexa Research has segmented the China bioprocess instruments market based on type: Segmentation by type, 2014 - 2024 (USD Million) • Cell Expansion • Flow Cytometry • Biologics Safety Testing • Cell Line Development • Tangential Flow Filtration • Cell Counters • Virus Filtration • Cell Culture • Pyrogen Testing Follow Us: Your Catalyst To a Lucrative Business • Single-Use Bioprocessing Browse Related Category Market Reports @ https://www.hexaresearch.com/researchcategory/pharmaceuticals-industry Follow Us: Your Catalyst To a Lucrative Business Table of Content of China Bioprocess Instruments Market Chapter 1 Market Summary 1.1 Market trends & movement Chapter 2 Bioprocess Instruments Market Trends: Drivers & Opportunities 2.1 Introduction 2.2 Key industry trends 2.3 Market driver analysis 2.3.1 Rising prevalence of chronic diseases 2.3.2 Growth in R&D activities in biopharmaceutical industry and life sciences 2.3.3 Market restraint 2.3.4 Stringent regulatory policies 2.4 Value chain analysis 2.5 SWOT 2.6 Porter’s Five Forces’ analysis Chapter 3 Bioprocess Instruments Market, By Type 3.1 Bioprocess instruments market movement, by type, 2016 & 2024 3.2 Cell Expansion 3.2.1 Market estimates and forecast, 2014 - 2024 (USD Million) 3.3 Flow Cytometry 3.3.1 Market estimates and forecast, 2014 - 2024 (USD Million) 3.4 Biological Safety Testing 3.4.1 Market estimates and forecast, 2014 - 2024 (USD Million) 3.5 Cell Line Development 3.5.1 Market estimates and forecast, 2014 - 2024 (USD Million) 3.6 Tangential Flow Filtration 3.6.1 Market estimates and forecast, 2014 - 2024 (USD Million) 3.7 Cell Counter 3.7.1 Market estimates and forecast, 2014 - 2024 (USD Million) 3.8 Cell Culture 3.8.1 Market estimates and forecast, 2014 - 2024 (USD Million) 3.9 Pyrogen Testing 3.9.1 Market estimates and forecast, 2014 - 2024 (USD Million) 3.10 Single Use Bioprocessing 3.10.1 Market estimates and forecast, 2014 - 2024 (USD Million) 3.11 Virus Filtration Follow Us: Your Catalyst To a Lucrative Business 3.11.1 Market estimates and forecast, 2014 - 2024 (USD Million) Chapter 4 Competitive Landscape 4.1 Competitive landscape analysis, 2016 4.2 Strategic framework 4.3 Potential customer base 4.4 Company market positioning 4.5 Company profiles 4.5.1 Abbott 18.104.22.168 Company Overview 22.214.171.124 Financial performance 126.96.36.199 Product benchmarking 188.8.131.52 Recent Initiatives 4.5.2 Thermo Fisher Scientific Inc. 184.108.40.206 Company Overview 220.127.116.11 Product benchmarking 18.104.22.168 Financial performance 22.214.171.124 Recent Initiatives 4.5.3 Alere Inc. 126.96.36.199 Company overview 188.8.131.52 Product benchmarking 184.108.40.206 Financial performance 220.127.116.11 Recent Initiatives 4.5.4 Becton, Dickinson and Company (BD) 18.104.22.168 Company Overview 22.214.171.124 Product benchmarking 126.96.36.199 Financial performance 188.8.131.52 Recent Initiatives 4.5.5 Koninklijke Philips N.V. 184.108.40.206 Company Overview 220.127.116.11 Product benchmarking 18.104.22.168 Financial performance 22.214.171.124 Recent Initiatives 4.5.6 PerkinElmer, Inc. 126.96.36.199 Company overview 188.8.131.52 Financial performance 184.108.40.206 Product benchmarking Follow Us: Your Catalyst To a Lucrative Business 220.127.116.11 Recent Initiatives 4.5.7 Danaher 18.104.22.168 Company Overview 22.214.171.124 Financial performance 126.96.36.199 Recent Initiatives 4.5.8 SHIMADZU CORPORATION 188.8.131.52 Company overview 184.108.40.206 Financial performance 220.127.116.11 Product benchmarking 18.104.22.168 Recent Initiatives 4.5.9 CESCO BIOENGINEERING CO., LTD 22.214.171.124 Company overview 126.96.36.199 Product benchmarking 4.5.10 Shanghai RITAI medicine equipment project co., ltd 188.8.131.52 Company overview 184.108.40.206 Product benchmarking 4.6 List of Other Vendors Chapter 5 Methodology and Scope 5.1 Research Methodology 5.2 Research Scope & Assumptions 5.3 List of Data Sources Follow Us: Your Catalyst To a Lucrative Business About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Follow Us: